CRP and Increased total eosinophil count: Immunoallergic liver injury mainly develops within 8 weeks after the initiation of DCV plus ASV therapy and is associated with eosinophilia and serum CRP elevation, while toxic liver injury occurs later than 8 weeks after the start of therapy [12].